富智康(02038.HK)料中期虧損收窄至3,000萬美元或以下
富智康(02038.HK)預期,截至6月底止上半年集團可能錄得綜合淨虧損約3,000萬美元或以下,對比2020年同期綜合淨虧損約為1.01億美元;期內營業收入預期達到39.38億美元,較2020年同期的36.68億美元增加。
富智康預計上半年持續進行優化或重組所產生之成本、開支或虧損總數約為1,700萬美元或以下,其中包括由集團因減損、處置或撇銷未充分利用、陳舊、已折舊資產而產生之虧損約為700萬美元或以下。
集團預料,目前財務資源及營運資金仍然足以為其持續經營業務及資本承擔提供資金,將有足夠資金應付未來十八個月之營運資金及資本開支需求,及無重大事件或情況可能不利影響集團履行財務責任或債務契約之能力至重大程度。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.